ARTICLE | Clinical News
Dalbavancin: Additional Phase III data
January 21, 2013 8:00 AM UTC
In a subgroup of patients with methicillin-resistant Staphylococcus aureus (MRSA), dalbavancin led to an early response defined as cessation of spread of the erythema of the lesion and resolution of f...